Home » TEVA PHARMACEUTICAL REPORTS A LOSS ON ACQUISITION
TEVA PHARMACEUTICAL REPORTS A LOSS ON ACQUISITION
May 10, 2006
Teva Pharmaceutical Industries Ltd, pharmaceutical company, reversed to a Q1
loss of $1.40 per ADR, down from a profit of 38 cents per ADR a year-ago. On
an adjusted basis, before one-time charges, it earned 37 cents per ADR.